IPO registrations (S-1, F-1) · Registrants

NRX Pharmaceuticals, Inc.

SEC CIK
1719406 · filings on EDGAR ↗
Former names
Big Rock Partners Acquisition Corp. (2017–2021)
Registration
Form S-1, first filed 2017-10-13, last 2024-11-14; 5 initial registrations, 4 amendments
Outcome
Final prospectus filed 2017-11-21; declared effective 2017-11-20; withdrawal requested 2025-06-24
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1201 ORANGE STREET, SUITE 600, Wilmington, DE 19801
EIN
82-2844431
Ticker
NRXP (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
NRX Pharmaceuticals, Inc. on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2017-11-21, an initial public offering)
Shares sold
6,000,000
Gross proceeds
$60,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol BRPA
Lead underwriters
I-Bankers Securities (600,000 shares)
Syndicate
Units EarlyBirdCapital, Inc (5,400,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 22

FiledFormWhat it isName as filedEDGAR
2017-10-13S-1S-1 (registration)Big Rock Partners Acquisition Corp.0001654954-17-009431 ↗
2017-11-14S-1/AS-1/A (amendment)Big Rock Partners Acquisition Corp.0001654954-17-010676 ↗
2017-11-17S-1/AS-1/A (amendment)Big Rock Partners Acquisition Corp.0001654954-17-010852 ↗
2017-11-20S-1/AS-1/A (amendment)Big Rock Partners Acquisition Corp.0001654954-17-010894 ↗
2017-11-20S-1MEFS-1MEF (added securities)Big Rock Partners Acquisition Corp.0001654954-17-010897 ↗
2017-11-20EFFECTEFFECT (declared effective)Big Rock Partners Acquisition Corp.9999999995-17-003025 ↗
2017-11-21424B4424B4 (final prospectus)Big Rock Partners Acquisition Corp.0001654954-17-010931 ↗
2021-05-21EFFECTEFFECT (declared effective)Big Rock Partners Acquisition Corp.9999999995-21-002054 ↗
2021-06-25S-1S-1 (registration)NRX Pharmaceuticals, Inc.0001193125-21-200558 ↗
2021-07-06S-1/AS-1/A (amendment)NRX Pharmaceuticals, Inc.0001193125-21-208673 ↗
2021-07-09EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-21-002705 ↗
2021-09-03S-1S-1 (registration)NRX Pharmaceuticals, Inc.0001104659-21-113002 ↗
2021-09-15EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-21-003551 ↗
2022-04-08S-1S-1 (registration)NRX Pharmaceuticals, Inc.0001104659-22-044187 ↗
2022-04-19EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-22-001031 ↗
2022-05-03EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-22-001274 ↗
2022-05-03EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-22-001282 ↗
2022-06-10EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-22-001758 ↗
2022-06-21EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-22-001833 ↗
2024-11-14S-1S-1 (registration)NRX Pharmaceuticals, Inc.0001437749-24-035167 ↗
2025-06-24RWRW (withdrawal request)NRX Pharmaceuticals, Inc.0001437749-25-021178 ↗
2025-12-22EFFECTEFFECT (declared effective)NRX Pharmaceuticals, Inc.9999999995-25-003879 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2017-11-20S-1/Aregistration statement$25.00--0primary document; price sentencedocument ↗
2017-11-21424B4final prospectus$10.006,000,000$60,000,000Nasdaq BRPA2primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ACKERMAN RICHARDDirector,Officer; Director,Officer,TenPercentOwnerPresident and CEO; President & CEO42017–2021
Big Rock Partners Sponsor, LLCDirector,Officer; TenPercentOwnerPresident and CEO42017–2021
BIRDOFF RICHARDDirector12017
FONG MICHAELDirector12017
KIM BENNETTOfficerChief Invt. Ofc. & Corp. Sec.12017
Koenig Stuart F.Director12017
REX ALBERT G.Director12017person page Fuzzy
Taylor Troy TDirector12017person page Fuzzy
Wittman LoriDirector,OfficerCFO12017
BRAC Lending Group LLCTenPercentOwner32018–2021
Levine StevenTenPercentOwner12018
NUSSBAUM DAVID MTenPercentOwner12018
Polar Asset Management Partners Inc.TenPercentOwner22020
Besthof RobertOfficerChief Comm. & Patient Officer; Interim CEO42021–2022
Daigneault AlessandraOfficerGeneral Counsel & Secretary32021
Flynn Patrick JohnDirector52021–2025
Fricker WilliamOfficerCFO & Treasurer22021
Glied SharonDirector32021–2022
Gorovitz AaronDirector42021–2023
Hurvitz ChaimDirector62021–2025
Javitt Daniel C.TenPercentOwner92021–2022
Javitt Jonathan CDirector,Officer,TenPercentOwner; Director,TenPercentOwnerChairman and Chief Scientist; Chief Executive Officer; Chief Scientist102021–2025
Troy DanielDirector22021
McMaster Herbert RaymondDirector22021
Strassberg Ira SOfficerChief Financial Officer12022
VAN VOORHEES SETHOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER42022
Willard Stephen HDirector,OfficerChief Executive Officer; CHIEF EXECUTIVE OFFICER22022
Narido Richard ClavanoOfficerInterim CFO12023
Rehnquist JanetDirector12024
McBride DennisDirector22024–2025
ABRAMS MICHAEL SOfficerChief Financial Officer22024–2025
B Group, Inc.TenPercentOwner12025
Casper Joseph MichaelOfficerChief Operating Officer22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2025-03-07NRX Pharmaceuticals, Inc.Biotechnology$3,500,000$3,500,00021
2017-11-22Big Rock Partners Acquisition Corp.Commercial$2,750,000$2,525,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationBIG ROCK PARTNERS ACQUISITION CORP.FLState business registriesEIN (EXACT, as the state registration reports it)
Business registrationNRX PHARMACEUTICALS, INC.FLState business registriesEIN (EXACT, as the state registration reports it)
ContractorFIVE JARSDENonprofit contractors (Form 990)same street address and ZIP code, 1201 ORANGE ST STE 600 19801 (FUZZY: a shared address, not proof of a shared organization)
Form D issuerNRX Pharmaceuticals, Inc.DEForm D private offeringsCIK (EXACT)
Lobbying clientNRX PHARMACEUTICALSDEFederal lobbying (LDA)name and state
Lobbying clientNRX PHARMACEUTICALSDEFederal lobbying (LDA)name and state
SEC filerNRX Pharmaceuticals, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerNRx PharmaceuticalsDETrademarks (USPTO)name and state
Person pageAlbert G RexPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageTroy T TaylorPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, DE first:

More with this interest.

In other datasets, the same topic (Health) in DE:

Interests: Pharmaceutical Preparations · Health